The U.K.-based drugmaker plans to invest $50 billion in the United States as the industry seeks to appease President Trump.
Source link
AstraZeneca Joins Pharma Investment Push in U.S. Amid Tariff Threat
Related Posts
Fact of the Week – 10/6/2025
#Factoftheweek AI (artificial intelligence) spending is about to hit $1.5 trillion in 2025, and this is just the beginning. Gartner projects global AI investment will soar past $2 trillion in…
Success Stories: Tech Reshapes Research
Universities are increasingly innovating how research support is delivered as demands for advanced information technology grow. As one example, Texas A&M AgriLife is piloting a new model for tech access…
